ReviewHealth science reports2026
A Systematic Review on the Economic Burden of the Most Prevalent Infectious Diseases in West Africa.
Review in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Systematic Review on the Economic Burden of the Most Prevalent Infectious Diseases in West Africa.Health science reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Background and Aim: Infectious diseases, including malaria, tuberculosis, cholera, and Lassa fever, pose a significant public health and economic challenge in West Africa. The financial burden includes direct medical costs (hospitalization, medication, diagnostics), nonmedical costs (transportation, food, caregiving), and indirect costs (loss of productivity, long-term disability, and mortality). Despite numerous economic studies on these diseases, there is limited research integrating actuarial modeling to quantify financial risks and propose mitigation strategies. Methods: This review includes 50 studies, indicating that malaria alone contributes to 2% GDP loss in Nigeria, while tuberculosis treatment in Ghana costs $500-$1000 per patient. Actuarial methods provide a structured approach to understanding cost variability, disease risk exposure, and sustainable financial interventions. This systematic review examines the economic burden of the most prevalent infectious diseases in West Africa, synthesizes relevant literature, and explores actuarial modeling as a tool for estimating long-term economic implications. Thus, by analyzing cost distributions, insurance models, and risk assessment strategies, the study highlights the significance of financial planning in disease management. Data sources used in this systematic review include academic journals, health organizations, and government reports. Conclusion: The findings emphasize the necessity of integrating financial risk management approaches, including insurance models and targeted public health investments, to mitigate the economic impact of these diseases and economic losses. The study highlights policy recommendations for governments and health institutions in the region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.